The global market for Bioconjugation Service was valued at US$ 673 million in the year 2024 and is projected to reach a revised size of US$ 968 million by 2031, growing at a CAGR of 5.4% during the forecast period.

Bioconjugation Service Market

Bioconjugation service is a specialized offering in the life sciences and biotechnology fields. It involves the process of covalently or non - covalently linking two or more biological molecules, or a biological molecule with a non - biological entity, such as a drug, a nanoparticle, or a fluorophore. Specialized techniques and expertise are employed to ensure the specificity, stability, and functionality of these conjugates. This service is tailored to meet the diverse needs of clients, including academic researchers exploring molecular interactions, pharmaceutical companies developing novel drug - delivery systems, and diagnostic firms aiming to create more sensitive and specific detection tools.

North American market for Bioconjugation Service is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Asia-Pacific market for Bioconjugation Service is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The global market for Bioconjugation Service in Pharmaceutical is estimated to increase from $ million in 2024 to $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The major global companies of Bioconjugation Service include AxisPharm, CellMosaic, Bio-Synthesis, GBI, Lonza, NJ Bio, WuXi Biologics, Creative Biolabs, Biosynth, Antibody Solutions, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

This report aims to provide a comprehensive presentation of the global market for Bioconjugation Service, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Bioconjugation Service.

The Bioconjugation Service market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Bioconjugation Service market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Bioconjugation Service companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of Bioconjugation Service Market Report

Report Metric	Details
Report Name	Bioconjugation Service Market
Accounted market size in year	US$ 673 million
Forecasted market size in 2031	US$ 968 million
CAGR	5.4%
Base Year	year
Forecasted years	2025 - 2031
Segment by Type	Protein Bioconjugation Antibody Bioconjugation Peptide Bioconjugation Others
Segment by Application	Pharmaceutical Diagnostics Biotechnology Research
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	AxisPharm, CellMosaic, Bio-Synthesis, GBI, Lonza, NJ Bio, WuXi Biologics, Creative Biolabs, Biosynth, Antibody Solutions, CheMatech, Thermo Fisher Scientific Inc, BOC Sciences, GTP Bioways, LifeSynth Solutions, iQ Biosciences, Macrocyclics, piramal pharma solutions
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Bioconjugation Service company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

FAQ for this report

How fast is Bioconjugation Service Market growing?

Ans: The Bioconjugation Service Market witnessing a CAGR of 5.4% during the forecast period 2025-2031.

What is the Bioconjugation Service Market size in 2031?

Ans: The Bioconjugation Service Market size in 2031 will be US$ 968 million.

Who are the main players in the Bioconjugation Service Market report?

Ans: The main players in the Bioconjugation Service Market are AxisPharm, CellMosaic, Bio-Synthesis, GBI, Lonza, NJ Bio, WuXi Biologics, Creative Biolabs, Biosynth, Antibody Solutions, CheMatech, Thermo Fisher Scientific Inc, BOC Sciences, GTP Bioways, LifeSynth Solutions, iQ Biosciences, Macrocyclics, piramal pharma solutions

What are the Application segmentation covered in the Bioconjugation Service Market report?

Ans: The Applications covered in the Bioconjugation Service Market report are Pharmaceutical, Diagnostics, Biotechnology Research

What are the Type segmentation covered in the Bioconjugation Service Market report?

Ans: The Types covered in the Bioconjugation Service Market report are Protein Bioconjugation, Antibody Bioconjugation, Peptide Bioconjugation, Others

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Bioconjugation Service Market Size Growth Rate by Type: 2020 VS 2024 VS 2031

1.2.2 Protein Bioconjugation

1.2.3 Antibody Bioconjugation

1.2.4 Peptide Bioconjugation

1.2.5 Others

1.3 Market by Application

1.3.1 Global Bioconjugation Service Market Growth by Application: 2020 VS 2024 VS 2031

1.3.2 Pharmaceutical

1.3.3 Diagnostics

1.3.4 Biotechnology Research

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Global Growth Trends

2.1 Global Bioconjugation Service Market Perspective (2020-2031)

2.2 Global Bioconjugation Service Growth Trends by Region

2.2.1 Global Bioconjugation Service Market Size by Region: 2020 VS 2024 VS 2031

2.2.2 Bioconjugation Service Historic Market Size by Region (2020-2025)

2.2.3 Bioconjugation Service Forecasted Market Size by Region (2026-2031)

2.3 Bioconjugation Service Market Dynamics

2.3.1 Bioconjugation Service Industry Trends

2.3.2 Bioconjugation Service Market Drivers

2.3.3 Bioconjugation Service Market Challenges

2.3.4 Bioconjugation Service Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Bioconjugation Service Players by Revenue

3.1.1 Global Top Bioconjugation Service Players by Revenue (2020-2025)

3.1.2 Global Bioconjugation Service Revenue Market Share by Players (2020-2025)

3.2 Global Top Bioconjugation Service Players by Company Type and Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Global Key Players Ranking by Bioconjugation Service Revenue

3.4 Global Bioconjugation Service Market Concentration Ratio

3.4.1 Global Bioconjugation Service Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Bioconjugation Service Revenue in 2024

3.5 Global Key Players of Bioconjugation Service Head office and Area Served

3.6 Global Key Players of Bioconjugation Service, Product and Application

3.7 Global Key Players of Bioconjugation Service, Date of Enter into This Industry

3.8 Mergers & Acquisitions, Expansion Plans

4 Bioconjugation Service Breakdown Data by Type

4.1 Global Bioconjugation Service Historic Market Size by Type (2020-2025)

4.2 Global Bioconjugation Service Forecasted Market Size by Type (2026-2031)

5 Bioconjugation Service Breakdown Data by Application

5.1 Global Bioconjugation Service Historic Market Size by Application (2020-2025)

5.2 Global Bioconjugation Service Forecasted Market Size by Application (2026-2031)

6 North America

6.1 North America Bioconjugation Service Market Size (2020-2031)

6.2 North America Bioconjugation Service Market Growth Rate by Country: 2020 VS 2024 VS 2031

6.3 North America Bioconjugation Service Market Size by Country (2020-2025)

6.4 North America Bioconjugation Service Market Size by Country (2026-2031)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Bioconjugation Service Market Size (2020-2031)

7.2 Europe Bioconjugation Service Market Growth Rate by Country: 2020 VS 2024 VS 2031

7.3 Europe Bioconjugation Service Market Size by Country (2020-2025)

7.4 Europe Bioconjugation Service Market Size by Country (2026-2031)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8 Asia-Pacific

8.1 Asia-Pacific Bioconjugation Service Market Size (2020-2031)

8.2 Asia-Pacific Bioconjugation Service Market Growth Rate by Region: 2020 VS 2024 VS 2031

8.3 Asia-Pacific Bioconjugation Service Market Size by Region (2020-2025)

8.4 Asia-Pacific Bioconjugation Service Market Size by Region (2026-2031)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9 Latin America

9.1 Latin America Bioconjugation Service Market Size (2020-2031)

9.2 Latin America Bioconjugation Service Market Growth Rate by Country: 2020 VS 2024 VS 2031

9.3 Latin America Bioconjugation Service Market Size by Country (2020-2025)

9.4 Latin America Bioconjugation Service Market Size by Country (2026-2031)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Bioconjugation Service Market Size (2020-2031)

10.2 Middle East & Africa Bioconjugation Service Market Growth Rate by Country: 2020 VS 2024 VS 2031

10.3 Middle East & Africa Bioconjugation Service Market Size by Country (2020-2025)

10.4 Middle East & Africa Bioconjugation Service Market Size by Country (2026-2031)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 AxisPharm

11.1.1 AxisPharm Company Details

11.1.2 AxisPharm Business Overview

11.1.3 AxisPharm Bioconjugation Service Introduction

11.1.4 AxisPharm Revenue in Bioconjugation Service Business (2020-2025)

11.1.5 AxisPharm Recent Development

11.2 CellMosaic

11.2.1 CellMosaic Company Details

11.2.2 CellMosaic Business Overview

11.2.3 CellMosaic Bioconjugation Service Introduction

11.2.4 CellMosaic Revenue in Bioconjugation Service Business (2020-2025)

11.2.5 CellMosaic Recent Development

11.3 Bio-Synthesis

11.3.1 Bio-Synthesis Company Details

11.3.2 Bio-Synthesis Business Overview

11.3.3 Bio-Synthesis Bioconjugation Service Introduction

11.3.4 Bio-Synthesis Revenue in Bioconjugation Service Business (2020-2025)

11.3.5 Bio-Synthesis Recent Development

11.4 GBI

11.4.1 GBI Company Details

11.4.2 GBI Business Overview

11.4.3 GBI Bioconjugation Service Introduction

11.4.4 GBI Revenue in Bioconjugation Service Business (2020-2025)

11.4.5 GBI Recent Development

11.5 Lonza

11.5.1 Lonza Company Details

11.5.2 Lonza Business Overview

11.5.3 Lonza Bioconjugation Service Introduction

11.5.4 Lonza Revenue in Bioconjugation Service Business (2020-2025)

11.5.5 Lonza Recent Development

11.6 NJ Bio

11.6.1 NJ Bio Company Details

11.6.2 NJ Bio Business Overview

11.6.3 NJ Bio Bioconjugation Service Introduction

11.6.4 NJ Bio Revenue in Bioconjugation Service Business (2020-2025)

11.6.5 NJ Bio Recent Development

11.7 WuXi Biologics

11.7.1 WuXi Biologics Company Details

11.7.2 WuXi Biologics Business Overview

11.7.3 WuXi Biologics Bioconjugation Service Introduction

11.7.4 WuXi Biologics Revenue in Bioconjugation Service Business (2020-2025)

11.7.5 WuXi Biologics Recent Development

11.8 Creative Biolabs

11.8.1 Creative Biolabs Company Details

11.8.2 Creative Biolabs Business Overview

11.8.3 Creative Biolabs Bioconjugation Service Introduction

11.8.4 Creative Biolabs Revenue in Bioconjugation Service Business (2020-2025)

11.8.5 Creative Biolabs Recent Development

11.9 Biosynth

11.9.1 Biosynth Company Details

11.9.2 Biosynth Business Overview

11.9.3 Biosynth Bioconjugation Service Introduction

11.9.4 Biosynth Revenue in Bioconjugation Service Business (2020-2025)

11.9.5 Biosynth Recent Development

11.10 Antibody Solutions

11.10.1 Antibody Solutions Company Details

11.10.2 Antibody Solutions Business Overview

11.10.3 Antibody Solutions Bioconjugation Service Introduction

11.10.4 Antibody Solutions Revenue in Bioconjugation Service Business (2020-2025)

11.10.5 Antibody Solutions Recent Development

11.11 CheMatech

11.11.1 CheMatech Company Details

11.11.2 CheMatech Business Overview

11.11.3 CheMatech Bioconjugation Service Introduction

11.11.4 CheMatech Revenue in Bioconjugation Service Business (2020-2025)

11.11.5 CheMatech Recent Development

11.12 Thermo Fisher Scientific Inc

11.12.1 Thermo Fisher Scientific Inc Company Details

11.12.2 Thermo Fisher Scientific Inc Business Overview

11.12.3 Thermo Fisher Scientific Inc Bioconjugation Service Introduction

11.12.4 Thermo Fisher Scientific Inc Revenue in Bioconjugation Service Business (2020-2025)

11.12.5 Thermo Fisher Scientific Inc Recent Development

11.13 BOC Sciences

11.13.1 BOC Sciences Company Details

11.13.2 BOC Sciences Business Overview

11.13.3 BOC Sciences Bioconjugation Service Introduction

11.13.4 BOC Sciences Revenue in Bioconjugation Service Business (2020-2025)

11.13.5 BOC Sciences Recent Development

11.14 GTP Bioways

11.14.1 GTP Bioways Company Details

11.14.2 GTP Bioways Business Overview

11.14.3 GTP Bioways Bioconjugation Service Introduction

11.14.4 GTP Bioways Revenue in Bioconjugation Service Business (2020-2025)

11.14.5 GTP Bioways Recent Development

11.15 LifeSynth Solutions

11.15.1 LifeSynth Solutions Company Details

11.15.2 LifeSynth Solutions Business Overview

11.15.3 LifeSynth Solutions Bioconjugation Service Introduction

11.15.4 LifeSynth Solutions Revenue in Bioconjugation Service Business (2020-2025)

11.15.5 LifeSynth Solutions Recent Development

11.16 iQ Biosciences

11.16.1 iQ Biosciences Company Details

11.16.2 iQ Biosciences Business Overview

11.16.3 iQ Biosciences Bioconjugation Service Introduction

11.16.4 iQ Biosciences Revenue in Bioconjugation Service Business (2020-2025)

11.16.5 iQ Biosciences Recent Development

11.17 Macrocyclics

11.17.1 Macrocyclics Company Details

11.17.2 Macrocyclics Business Overview

11.17.3 Macrocyclics Bioconjugation Service Introduction

11.17.4 Macrocyclics Revenue in Bioconjugation Service Business (2020-2025)

11.17.5 Macrocyclics Recent Development

11.18 piramal pharma solutions

11.18.1 piramal pharma solutions Company Details

11.18.2 piramal pharma solutions Business Overview

11.18.3 piramal pharma solutions Bioconjugation Service Introduction

11.18.4 piramal pharma solutions Revenue in Bioconjugation Service Business (2020-2025)

11.18.5 piramal pharma solutions Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.1.1 Research Programs/Design

13.1.1.2 Market Size Estimation

13.1.1.3 Market Breakdown and Data Triangulation

13.1.2 Data Source

13.1.2.1 Secondary Sources

13.1.2.2 Primary Sources

13.2 Author Details

13.3 Disclaimer

FEATURED COMPANIES

Thermo Fisher Scientific Inc

Piramal Pharma Solutions

LifeSynth Solutions

List of Tables

Table 1. Global Bioconjugation Service Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031

Table 2. Key Players of Protein Bioconjugation

Table 3. Key Players of Antibody Bioconjugation

Table 4. Key Players of Peptide Bioconjugation

Table 5. Key Players of Others

Table 6. Global Bioconjugation Service Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031

Table 7. Global Bioconjugation Service Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Table 8. Global Bioconjugation Service Market Size by Region (2020-2025) & (US$ Million)

Table 9. Global Bioconjugation Service Market Share by Region (2020-2025)

Table 10. Global Bioconjugation Service Forecasted Market Size by Region (2026-2031) & (US$ Million)

Table 11. Global Bioconjugation Service Market Share by Region (2026-2031)

Table 12. Bioconjugation Service Market Trends

Table 13. Bioconjugation Service Market Drivers

Table 14. Bioconjugation Service Market Challenges

Table 15. Bioconjugation Service Market Restraints

Table 16. Global Bioconjugation Service Revenue by Players (2020-2025) & (US$ Million)

Table 17. Global Bioconjugation Service Market Share by Players (2020-2025)

Table 18. Global Top Bioconjugation Service Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Bioconjugation Service as of 2024)

Table 19. Ranking of Global Top Bioconjugation Service Companies by Revenue (US$ Million) in 2024

Table 20. Global 5 Largest Players Market Share by Bioconjugation Service Revenue (CR5 and HHI) & (2020-2025)

Table 21. Global Key Players of Bioconjugation Service, Headquarters and Area Served

Table 22. Global Key Players of Bioconjugation Service, Product and Application

Table 23. Global Key Players of Bioconjugation Service, Date of Enter into This Industry

Table 24. Mergers & Acquisitions, Expansion Plans

Table 25. Global Bioconjugation Service Market Size by Type (2020-2025) & (US$ Million)

Table 26. Global Bioconjugation Service Revenue Market Share by Type (2020-2025)

Table 27. Global Bioconjugation Service Forecasted Market Size by Type (2026-2031) & (US$ Million)

Table 28. Global Bioconjugation Service Revenue Market Share by Type (2026-2031)

Table 29. Global Bioconjugation Service Market Size by Application (2020-2025) & (US$ Million)

Table 30. Global Bioconjugation Service Revenue Market Share by Application (2020-2025)

Table 31. Global Bioconjugation Service Forecasted Market Size by Application (2026-2031) & (US$ Million)

Table 32. Global Bioconjugation Service Revenue Market Share by Application (2026-2031)

Table 33. North America Bioconjugation Service Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 34. North America Bioconjugation Service Market Size by Country (2020-2025) & (US$ Million)

Table 35. North America Bioconjugation Service Market Size by Country (2026-2031) & (US$ Million)

Table 36. Europe Bioconjugation Service Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 37. Europe Bioconjugation Service Market Size by Country (2020-2025) & (US$ Million)

Table 38. Europe Bioconjugation Service Market Size by Country (2026-2031) & (US$ Million)

Table 39. Asia-Pacific Bioconjugation Service Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031

Table 40. Asia-Pacific Bioconjugation Service Market Size by Region (2020-2025) & (US$ Million)

Table 41. Asia-Pacific Bioconjugation Service Market Size by Region (2026-2031) & (US$ Million)

Table 42. Latin America Bioconjugation Service Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 43. Latin America Bioconjugation Service Market Size by Country (2020-2025) & (US$ Million)

Table 44. Latin America Bioconjugation Service Market Size by Country (2026-2031) & (US$ Million)

Table 45. Middle East & Africa Bioconjugation Service Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 46. Middle East & Africa Bioconjugation Service Market Size by Country (2020-2025) & (US$ Million)

Table 47. Middle East & Africa Bioconjugation Service Market Size by Country (2026-2031) & (US$ Million)

Table 48. AxisPharm Company Details

Table 49. AxisPharm Business Overview

Table 50. AxisPharm Bioconjugation Service Product

Table 51. AxisPharm Revenue in Bioconjugation Service Business (2020-2025) & (US$ Million)

Table 52. AxisPharm Recent Development

Table 53. CellMosaic Company Details

Table 54. CellMosaic Business Overview

Table 55. CellMosaic Bioconjugation Service Product

Table 56. CellMosaic Revenue in Bioconjugation Service Business (2020-2025) & (US$ Million)

Table 57. CellMosaic Recent Development

Table 58. Bio-Synthesis Company Details

Table 59. Bio-Synthesis Business Overview

Table 60. Bio-Synthesis Bioconjugation Service Product

Table 61. Bio-Synthesis Revenue in Bioconjugation Service Business (2020-2025) & (US$ Million)

Table 62. Bio-Synthesis Recent Development

Table 63. GBI Company Details

Table 64. GBI Business Overview

Table 65. GBI Bioconjugation Service Product

Table 66. GBI Revenue in Bioconjugation Service Business (2020-2025) & (US$ Million)

Table 67. GBI Recent Development

Table 68. Lonza Company Details

Table 69. Lonza Business Overview

Table 70. Lonza Bioconjugation Service Product

Table 71. Lonza Revenue in Bioconjugation Service Business (2020-2025) & (US$ Million)

Table 72. Lonza Recent Development

Table 73. NJ Bio Company Details

Table 74. NJ Bio Business Overview

Table 75. NJ Bio Bioconjugation Service Product

Table 76. NJ Bio Revenue in Bioconjugation Service Business (2020-2025) & (US$ Million)

Table 77. NJ Bio Recent Development

Table 78. WuXi Biologics Company Details

Table 79. WuXi Biologics Business Overview

Table 80. WuXi Biologics Bioconjugation Service Product

Table 81. WuXi Biologics Revenue in Bioconjugation Service Business (2020-2025) & (US$ Million)

Table 82. WuXi Biologics Recent Development

Table 83. Creative Biolabs Company Details

Table 84. Creative Biolabs Business Overview

Table 85. Creative Biolabs Bioconjugation Service Product

Table 86. Creative Biolabs Revenue in Bioconjugation Service Business (2020-2025) & (US$ Million)

Table 87. Creative Biolabs Recent Development

Table 88. Biosynth Company Details

Table 89. Biosynth Business Overview

Table 90. Biosynth Bioconjugation Service Product

Table 91. Biosynth Revenue in Bioconjugation Service Business (2020-2025) & (US$ Million)

Table 92. Biosynth Recent Development

Table 93. Antibody Solutions Company Details

Table 94. Antibody Solutions Business Overview

Table 95. Antibody Solutions Bioconjugation Service Product

Table 96. Antibody Solutions Revenue in Bioconjugation Service Business (2020-2025) & (US$ Million)

Table 97. Antibody Solutions Recent Development

Table 98. CheMatech Company Details

Table 99. CheMatech Business Overview

Table 100. CheMatech Bioconjugation Service Product

Table 101. CheMatech Revenue in Bioconjugation Service Business (2020-2025) & (US$ Million)

Table 102. CheMatech Recent Development

Table 103. Thermo Fisher Scientific Inc Company Details

Table 104. Thermo Fisher Scientific Inc Business Overview

Table 105. Thermo Fisher Scientific Inc Bioconjugation Service Product

Table 106. Thermo Fisher Scientific Inc Revenue in Bioconjugation Service Business (2020-2025) & (US$ Million)

Table 107. Thermo Fisher Scientific Inc Recent Development

Table 108. BOC Sciences Company Details

Table 109. BOC Sciences Business Overview

Table 110. BOC Sciences Bioconjugation Service Product

Table 111. BOC Sciences Revenue in Bioconjugation Service Business (2020-2025) & (US$ Million)

Table 112. BOC Sciences Recent Development

Table 113. GTP Bioways Company Details

Table 114. GTP Bioways Business Overview

Table 115. GTP Bioways Bioconjugation Service Product

Table 116. GTP Bioways Revenue in Bioconjugation Service Business (2020-2025) & (US$ Million)

Table 117. GTP Bioways Recent Development

Table 118. LifeSynth Solutions Company Details

Table 119. LifeSynth Solutions Business Overview

Table 120. LifeSynth Solutions Bioconjugation Service Product

Table 121. LifeSynth Solutions Revenue in Bioconjugation Service Business (2020-2025) & (US$ Million)

Table 122. LifeSynth Solutions Recent Development

Table 123. iQ Biosciences Company Details

Table 124. iQ Biosciences Business Overview

Table 125. iQ Biosciences Bioconjugation Service Product

Table 126. iQ Biosciences Revenue in Bioconjugation Service Business (2020-2025) & (US$ Million)

Table 127. iQ Biosciences Recent Development

Table 128. Macrocyclics Company Details

Table 129. Macrocyclics Business Overview

Table 130. Macrocyclics Bioconjugation Service Product

Table 131. Macrocyclics Revenue in Bioconjugation Service Business (2020-2025) & (US$ Million)

Table 132. Macrocyclics Recent Development

Table 133. piramal pharma solutions Company Details

Table 134. piramal pharma solutions Business Overview

Table 135. piramal pharma solutions Bioconjugation Service Product

Table 136. piramal pharma solutions Revenue in Bioconjugation Service Business (2020-2025) & (US$ Million)

Table 137. piramal pharma solutions Recent Development

Table 138. Research Programs/Design for This Report

Table 139. Key Data Information from Secondary Sources

Table 140. Key Data Information from Primary Sources

Table 141. Authors List of This Report

List of Figures

Figure 1. Bioconjugation Service Picture

Figure 2. Global Bioconjugation Service Market Size Comparison by Type (2020-2031) & (US$ Million)

Figure 3. Global Bioconjugation Service Market Share by Type: 2024 VS 2031

Figure 4. Protein Bioconjugation Features

Figure 5. Antibody Bioconjugation Features

Figure 6. Peptide Bioconjugation Features

Figure 7. Others Features

Figure 8. Global Bioconjugation Service Market Size by Application (2020-2031) & (US$ Million)

Figure 9. Global Bioconjugation Service Market Share by Application: 2024 VS 2031

Figure 10. Pharmaceutical Case Studies

Figure 11. Diagnostics Case Studies

Figure 12. Biotechnology Research Case Studies

Figure 13. Bioconjugation Service Report Years Considered

Figure 14. Global Bioconjugation Service Market Size (US$ Million), Year-over-Year: 2020-2031

Figure 15. Global Bioconjugation Service Market Size, (US$ Million), 2020 VS 2024 VS 2031

Figure 16. Global Bioconjugation Service Market Share by Region: 2024 VS 2031

Figure 17. Global Bioconjugation Service Market Share by Players in 2024

Figure 18. Global Bioconjugation Service Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

Figure 19. The Top 10 and 5 Players Market Share by Bioconjugation Service Revenue in 2024

Figure 20. North America Bioconjugation Service Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 21. North America Bioconjugation Service Market Share by Country (2020-2031)

Figure 22. United States Bioconjugation Service Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 23. Canada Bioconjugation Service Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 24. Europe Bioconjugation Service Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 25. Europe Bioconjugation Service Market Share by Country (2020-2031)

Figure 26. Germany Bioconjugation Service Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 27. France Bioconjugation Service Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 28. U.K. Bioconjugation Service Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 29. Italy Bioconjugation Service Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 30. Russia Bioconjugation Service Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 31. Nordic Countries Bioconjugation Service Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 32. Asia-Pacific Bioconjugation Service Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 33. Asia-Pacific Bioconjugation Service Market Share by Region (2020-2031)

Figure 34. China Bioconjugation Service Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 35. Japan Bioconjugation Service Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 36. South Korea Bioconjugation Service Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 37. Southeast Asia Bioconjugation Service Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 38. India Bioconjugation Service Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 39. Australia Bioconjugation Service Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 40. Latin America Bioconjugation Service Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 41. Latin America Bioconjugation Service Market Share by Country (2020-2031)

Figure 42. Mexico Bioconjugation Service Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 43. Brazil Bioconjugation Service Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 44. Middle East & Africa Bioconjugation Service Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 45. Middle East & Africa Bioconjugation Service Market Share by Country (2020-2031)

Figure 46. Turkey Bioconjugation Service Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 47. Saudi Arabia Bioconjugation Service Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 48. UAE Bioconjugation Service Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 49. AxisPharm Revenue Growth Rate in Bioconjugation Service Business (2020-2025)

Figure 50. CellMosaic Revenue Growth Rate in Bioconjugation Service Business (2020-2025)

Figure 51. Bio-Synthesis Revenue Growth Rate in Bioconjugation Service Business (2020-2025)

Figure 52. GBI Revenue Growth Rate in Bioconjugation Service Business (2020-2025)

Figure 53. Lonza Revenue Growth Rate in Bioconjugation Service Business (2020-2025)

Figure 54. NJ Bio Revenue Growth Rate in Bioconjugation Service Business (2020-2025)

Figure 55. WuXi Biologics Revenue Growth Rate in Bioconjugation Service Business (2020-2025)

Figure 56. Creative Biolabs Revenue Growth Rate in Bioconjugation Service Business (2020-2025)

Figure 57. Biosynth Revenue Growth Rate in Bioconjugation Service Business (2020-2025)

Figure 58. Antibody Solutions Revenue Growth Rate in Bioconjugation Service Business (2020-2025)

Figure 59. CheMatech Revenue Growth Rate in Bioconjugation Service Business (2020-2025)

Figure 60. Thermo Fisher Scientific Inc Revenue Growth Rate in Bioconjugation Service Business (2020-2025)

Figure 61. BOC Sciences Revenue Growth Rate in Bioconjugation Service Business (2020-2025)

Figure 62. GTP Bioways Revenue Growth Rate in Bioconjugation Service Business (2020-2025)

Figure 63. LifeSynth Solutions Revenue Growth Rate in Bioconjugation Service Business (2020-2025)

Figure 64. iQ Biosciences Revenue Growth Rate in Bioconjugation Service Business (2020-2025)

Figure 65. Macrocyclics Revenue Growth Rate in Bioconjugation Service Business (2020-2025)

Figure 66. piramal pharma solutions Revenue Growth Rate in Bioconjugation Service Business (2020-2025)

Figure 67. Bottom-up and Top-down Approaches for This Report

Figure 68. Data Triangulation

Figure 69. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic

$2900

Single User License

Multi User

Electronic

$4350

Multi User License

Enterprise License

Electronic

$5800

Enterprise License

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions